Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 261-270 of 2762 for cancer

Edit search filters
  1. A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer

    Rochester, MN

  2. Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ

  3. Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

    Rochester, MN

  4. A Study of Pembrolizumab Alone as Therapy for Metastatic Triple-Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Phase 1/2, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients with Advanced Cancers

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study

    Jacksonville, FL

  9. Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer

  10. A Study to Evaluate Visually Inspired Patient Education Material on Willingness to Pursue Radiation Therapy

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer